Back to results

Queen's University Belfast

Development of fixed dose combinations using advanced engineering technologies

Abstract

dc:description.abstract

Traditionally manufacturing of drug formulations has been controlled by an established regulatory framework which ensured that final product quality was safeguarded. By carrying out testing of batch-based operations and comparison with raw material and end-product characteristics this quality is guaranteed. However, in recent years there has been increased interest in improving both the safety and the quality of formulated medications while simultaneously cutting costs. The industry has looked to move away from batch processing and towards continuous manufacturing.<br/><br/>Commonly used continuous manufacturing techniques including; hot-melt extrusion, spray-drying and hot-melt co-extrusion were employed throughout this thesis in order to produce fixed-dose combination products. Depending on the desired characteristics of the final formulation, selection of appropriate continuous manufacturing platform had a critical impact on the overall outcome. Several continuous manufacturing platforms, with particular focus on hot-melt extrusion, were successfully employed throughout this thesis, highlighting it as an advanced, engineering technology to produce fixed-dose combinations for the treatment of hypertension and to improve adherence.<br/><br/>Furthermore, a range of anti-hypertensive drugs were used throughout various chapters. These active pharmaceutical ingredients presented a range of therapeutic and manufacturing problems including; poor water solubility, thermolability or having a short half-life. Additional investigations were also carried out in order to overcome identified problems as they were met during the course of this research program including; swelling behaviour of polymeric carriers or to make use DOE and PAT in order to obtain a truly continuous manufacturing platform.

Degree

thesis:*
Name dc:type.qualificationname
Doctor of Philosophy
Level dc:type.qualificationlevel
Doctoral Thesis
Grantor dc:publisher.institution
Queen's University Belfast
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gilvary, Gareth C.
Advisors dc:contributor.advisor
  • Andrews, Gavin
  • Li, Shu

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
oai:pure.qub.ac.uk/portal:studenttheses/2f07a661-38ac-4ec9-aa80-31ea114e1b95
OAI identifier oai:identifier
oai:pure.qub.ac.uk/portal:studenttheses/2f07a661-38ac-4ec9-aa80-31ea114e1b95

Chain of custody

source
Harvested from
Queen's University Belfast
Base URL
pureadmin.qub.ac.uk/ws/oai
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Gilvary, Gareth C.. Development of fixed dose combinations using advanced engineering technologies. Doctoral Thesis thesis, Queen's University Belfast, 2021. https://pure.qub.ac.uk/en/studentTheses/2f07a661-38ac-4ec9-aa80-31ea114e1b95